Establishment and characterization of a new mantle cell lymphoma cell line M-1

Leukemia and Lymphoma

Volumn 45, Issue 6, 2004, Pages 1255-1260

  Goy, Andre ^a   Remache, Yvonne K ^a   Gu, Jun ^a   Stewart, John ^a   Hayes, Kimberly J ^a   Gold, David ^a   Jiang, Yunfang ^a   Barkoh, Bedia A ^a   Katz, Ruth ^a   Cabanillas, Fernando ^a   Gilles, Frederic ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

M 1 cell line; Mantle cell lymphoma; t(11; 14)(q13; q32)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 HYDROPEROXYCYCLOPHOSPHAMIDE; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN M; MEMBRANE ANTIGEN; PREDNISONE; RITUXIMAB; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL ASSAY; CELL MATURATION; CELL PROLIFERATION; CHROMOSOME 10; CHROMOSOME 3; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME Q BAND; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CYTOGENETICS; CYTOTOXICITY TEST; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; LEUKEMIA; LYMPHOMA CELL LINE; MALE; MANTLE CELL LYMPHOMA; MOLECULAR BIOLOGY; MOLECULAR MODEL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CELL DIVISION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 2342614155     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001642729     Document Type: Article

References (20)

1. Fisher, R.I. (1996) "Mantle-cell lymphoma: classification and therapeutic implications", Annals of Oncology, 7(Suppl 6), S35.
2. Barista, I., Romaguera, J.E. and Cabanillas, F. (2001) "Mantle-cell lymphoma" Lancet Oncol., 2, 141-148.
3. Hankin, R.C. and Hunter, S.V. (1999) "Mantle cell lymphoma", Archives of Pathology and Laboratory Medicine, 123, 1182.
4. Ott, G., Kalla, J., Hanke, A., Muller, J.G., Rosenwald, A., Katzenberger, T., et al. (1998) "The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features", Leukemia and Lymphoma, 32, 55.
5. Komatsu, H., Iida, S., Yamamoto, K., Mikuni, C., Nitta, M., Takahashi, T., et al. (1994) "A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene", Blood, 84, 1226.
6. Callanan, M., Leroux, D., Magaud, J.P. and Rimokh, R. (1996) "Implication of cyclin D1 in malignant lymphoma", Critical Reviews in Oncology, 7, 191.
7. Leonard, J.P., Schattner, E.J. and Coleman, M. (2001) "Biology and management of mantle cell lymphoma", Current Opinion in Oncology, 13, 342.
8. Schlette, E., Lai, R., Onciu, M., Doherty, D., Bueso-Ramos, C. and Medeiros, L.J. (2001) "Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases", Modern Pathology, 14, 1133.
9. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R., et al. (1996) "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis", Blood, 87, 4302.
10. Singleton, T.P., Anderson, M.M., Ross, C.W. and Schnitzer, B. (1999) "Leukemic phase of mantle cell lymphoma, blastoid variant", American Journal of Clinical Pathology, 111, 495.
11. Onciu, M., Schlette, E., Medeiros, L.J., Abruzzo, L.V., Keating, M. and Lai, R. (2001) "Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities", American Journal of Clinical Pathology, 116, 886.
12. Drexler, H.G. and MacLeod, R.A. (2002) "Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma", Leukemia Research, 26, 781.
13. Romaguera, J.E., Khouri, I.F., Kantarjian, H.M., Hagemeister, F.B., Rodriguez, M.A., McLaughlin, P., et al. (2000) "Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients", Leukemia and Lymphoma, 39, 77.
14. Katz, R.L., Caraway, N.P., Gu, J., Jiang, F., Pasco-Miller, L.A., Glassman, A.B., et al. (2000) "Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma", American Journal of Clinical Pathology, 114, 248.
15. Telenti, A., Marshall, W.F. and Smith, T.F. (1990) "Detection of Epstein-Barr virus by polymerase chain reaction" , Journal of Clinical Microbiology, 28, 2187.
16. Chibbar, R., Leung, K., McCormick, S., Ritzkalla, K., Strickler, J., Staggs, R., et al. (1998) "bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis", Modern Pathology, 11, 1089.
17. Olsson, K., Gerard, C.J., Zehnder, J., Jones, C., Ramanathan, R., Reading, C., et al. (1999) "Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)", Leukemia, 13, 1833.
18. Mittelman, F. (ed.) (1995) ISCN. An International System for Human Cytogenetic Nomenclature. Basel, CH: Krager.
19. Vizcarra, E., Martinez-Climent, J.A., Benet, I., Marugan, I., Terol, M.J., Prosper, F., et al. (2001) "Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features", Hematology Journal, 2, 234.
20. Daibata, M., Kubonishi, I., Eguchi, T., Yano, S. and Ohtsuki, Y. and Miyoshi, I. (1989) "The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma", Cancer, 64, 1248.